Little Green Pharma Ltd (ASX: LGP) has acquired a world-class, fully-operational, GMP medicinal cannabis cultivation and manufacturing facility in Denmark from Canopy Growth Corporation. The facility, located in Northern Odense, has the capacity to produce in excess of 12 tonnes per annum of finished flower and provides LGP with much-needed product supply from its current inventory of ~1 tonne of medicinal cannabis flower products. Previously operating as a production site, LGP hopes to broaden the facility’s service offering by building out a sales and marketing division and empowering the facility to engage with EU and global markets. LGP expects that its established brand and distribution channels and EU cannabis markets know-how will help generate additional valuable sales opportunities for the facility. The LGP Group will also share best-practice cultivation, manufacturing, and pharmaceutical insights and expertise between its global assets. The LGP Group plans to immediately focus on delivering products in Australia and Germany as it grows its portfolio of export destinations over time.

Published Ncv Newswire, New Cannabis Ventures, 06/22/2021 07:04:00

Open article: